Abstract PS2-09-09: Early on-treatment PD-L1 expression and stromal tumor infiltrating lymphocytes (sTILs) refine the prediction of EFS in the NeoTRIP trial
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institutions: IRCCS Ospedale San Raffaele, European Institute of Oncology, National Taiwan University, National Taiwan University Hospital, Innsbruck Medical University, Universität Innsbruck, Fondazione Michelangelo, University of Cambridge, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Agaplesion Markus Hospital, Universidad de Zaragoza, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón, Azienda sanitaria universitaria Friuli Centrale, Hospital Universitario 12 De Octubre, Paracelsus Medical University, Institute of Oncology NN Petrov, Ospedale Policlinico San Martino
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7130693396
Cites:
Cited by:
Related to: